Longitudinal changes in patient characteristics as drivers of clinical outcomes in the Early Undifferentiated PolyArthritis (EUPA) cohort
Compared with the INNOV period, patients recruited after 2011 presented with milder baseline characteristics and showed evidence for an amplified response to treatment during follow-up, contributing to higher remission rates. Nonetheless, improvements of function and other PROs remained similar across recruitment periods.
Authors
- Nathalie Carrier (ORCID: https://orcid.org/0000-0001-9689-5416)
- Gilles Boire (ORCID: https://orcid.org/0000-0003-2481-5821)
- Javier Marrugo (ORCID: https://orcid.org/0000-0001-9157-4269)
- Patrick Liang (ORCID: https://orcid.org/0000-0003-0089-5337)
- Misti L. Paudel (ORCID: https://orcid.org/0000-0002-8361-0650)
- Hugues Allard‐Chamard (ORCID: https://orcid.org/0000-0001-7850-2658)
- Sophie Roux (ORCID: https://orcid.org/0000-0002-7427-9361)
- Artur José de Brum Fernandes
Institutions
- Brigham and Women's Hospital (US)
- Université de Sherbrooke (CA)
- Harvard University (US)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-12-07
- DOI
- https://doi.org/10.1093/rheumatology/keaf650
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb Canada